Jefferies reiterates Protagonist Therapeutics stock rating on Mimrylo label strength
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
U.S. Treasury chief Bessent is rallying G20 allies on Iran as tariffs strain ties
Treasury Secretary Scott Bessent is meeting with finance ministers of the world’s largest economies this week at a time when the United States has disrupted the international order with aggressive…
Broadcom reports earnings this week. Mike Khouw says this trade could be a winner
"The stakes are high" heading into Broadcom earnings, says Mike Khouw.
Broadcom reports earnings this week. Mike Khouw says this trade could be a winner
"The stakes are high" heading into Broadcom earnings, says Mike Khouw.
Will the Stock Market Crash in 2027? Here's What We Know.
Key PointsAn expert on financial crises sounded an alarm this week with a grim 2027 market crash prediction.
Sources: Hyperliquid is in talks to enter the US market through Kraken parent Payward, weeks after Trump said he was working to bring the platform onshore (Bloomberg)
Hyperliquid Labs is in advanced talks to bring its perpetual futures to US traders through Kraken's parent company Payward …
‘Where are the jobs?’ Congress challenges PM Modi after 7.8% Q1 GDP growth data
India's economy grew by 7.8 percent in the April-June quarter. Congress questioned the growth's impact on jobs and prosperity.